SciELO - Scientific Electronic Library Online

 
vol.24 suppl.1Distribución de patrones PRA en aislamientos clínicos del complejo Mycobacterium avium procedentes de España y SuraméricaResistencia inicial a drogas antituberculosas en Buenaventura, Colombia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Biomédica

Print version ISSN 0120-4157On-line version ISSN 2590-7379

Abstract

TOBON, Ángela et al. Cirugía en tuberculosis pulmonar multirresistente. Biomédica [online]. 2004, vol.24, suppl.1, pp.65-72. ISSN 0120-4157.

Surgical treatment of multiresistant lung tuberculosis Drug resistance has become a major problem in the treatment of tuberculosis. Pulmonary resection in combination with chemotherapy appears to be an effective measure for the treatment of multi-drug resistant pulmonary tuberculosis. A retrospective review was performed of the medical and laboratory findings of 28 patients with multi-drug resistant tuberculosis who underwent pulmonary resection for pulmonary tuberculosis between January 1990 and December 2000 at La Maria Hospital, Medellín. Twenty-one of them had medical therapy before surgery; 14 patients underwent upper lobectomy and 10 patients pneumonectomy). The AFB negative sputum conversion rate was 88.9% (25/27) after surgery, during an average of 6 weeks. Bacteriological relapses were confirmed in 6 of 27, 4 of these 6 had AFB negative sputum. Twenty-eight patients had medical therapy after surgery. For selected patients, pulmonary resection in combination with chemotherapy should be considered an effective measure for treatment of multi-drug resistant pulmonary tuberculosis

Keywords : surgery; multi-drug resistant; pulmonary tuberculosis.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License